HW
IART icon

Hancock Whitney’s Integra LifeSciences IART Stock Holding History

Hancock Whitney’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-33,635
Closed -$1.38M – 632
2023
Q2 		$1.38M Sell
33,635
-1,658
-5% -$79.8K 0.05% 249
2023
Q1 		$2.03M Buy
35,293
+873
+3% +$49.2K 0.08% 199
2022
Q4 		$1.93M Sell
34,420
-3,714
-10% -$189K 0.07% 215
2022
Q3 		$1.61M Sell
38,134
-242
-0.6% -$12.4K 0.07% 222
2022
Q2 		$2.07M Sell
38,376
-380
-1% -$22.8K 0.08% 193
2022
Q1 		$2.49M Buy
38,756
+3,896
+11% +$257K 0.08% 189
2021
Q4 		$2.33M Sell
34,860
-484
-1% -$32.7K 0.07% 213
2021
Q3 		$2.42M Buy
35,344
+534
+2% +$37.7K 0.08% 194
2021
Q2 		$2.38M Buy
34,810
+18,944
+119% +$1.34M 0.08% 231
2021
Q1 		$1.1M Sell
15,866
-231
-1% -$15.7K 0.04% 392
2020
Q4 		$1.04M Sell
16,097
-409
-2% -$22K 0.03% 384
2020
Q3 		$779K Sell
16,506
-359
-2% -$17.1K 0.03% 417
2020
Q2 		$793K Buy
+16,865
New +$829K 0.03% 414

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hancock Whitney's IART Position: Q3 2023 in Review

Hancock Whitney sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 33,635 shares — an estimated $1.38M sold.

Hancock Whitney first reported a position in IART in Q2 2020 and held it in 13 quarters. The position peaked at $2.49M in Q1 2022. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

  • Hancock Whitney reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
  • Hancock Whitney sold 33,635 Integra LifeSciences shares in Q3 2023, an estimated $1.38M.
  • Hancock Whitney first reported a position in Integra LifeSciences in Q2 2020 and held it in 13 quarters.
  • Hancock Whitney's Integra LifeSciences position peaked at $2.49M in Q1 2022.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on Hancock Whitney's 13F filing for Q3 2023, filed 13 Nov 2023.